Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis

• Main Authors: Yasuhiko Koga (Author), Haruka Aoki-Saito (Author), Yosuke Kamide (Author), Makiko Sato (Author), Hiroaki Tsurumaki (Author), Masakiyo Yatomi (Author), Tamotsu Ishizuka (Author), Takeshi Hisada (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Two types of interleukin (IL)-5 antibody biologics, anti-IL-5 antibodies (mepolizumab) and anti-IL-5α receptor antibodies (benralizumab), are indicated for severe asthma. While high-dose mepolizumab is also indicated for EGPA, benralizumab is indicated only for severe asthma. Benralizumab is charact...